The most recent consensus algorithm released by the ADA/EASD lists GLP-1 analogues as a treatment option for consideration as a Tier 2 agent, or less well-validated therapy, in T2DM patients ( FIGURE 1 )
The Estimated Annual Cost of Uterine Leiomyomata in the United States
The Bottom Line Patients should have clear information about what these drugs can and cannot do, along with proper medical supervision that goes beyond just tracking weight, looking at muscle mass, nutrition, and overall health
Their model then calculates a prediction of death or recovery using using 30% remaining hepatocytes as the boundary between death and recovery
These common symptoms may include gastrointestinal issues, such as: Nausea Vomiting Diarrhea If these persist, patients must consult their providers for prompt action
Acta 1512 , 273284 (2001)